Deciphera Pharmaceuticals | SC TO-C: Written communication relating to an issuer or third party tender offer
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Deciphera Pharmaceuticals | SC14D9C: Written communication by the subject company relating to a third party tender offer
Deciphera Pharmaceuticals | 8-K: Current report
Deciphera Pharmaceuticals | ARS: Annual Report to Security Holders
Deciphera Pharmaceuticals | DEFA14A: Others
Deciphera Pharmaceuticals | DEF 14A: Definitive information statements
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Brightstar Associates LLC
Deciphera Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials
Deciphera Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sherman Matthew L
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Thomas Patrick
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Pitman Jama
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Martin Daniel C.
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dhanak Dashyant
Deciphera Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hoerter Steven L.
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%), etc.
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BRAIDWELL LP(2.92%),BRAIDWELL MANAGEMENT LLC(2.92%), etc.
Deciphera Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(6.49%),Steven Boyd(6.49%)
No Data